Contraceptive Development Research Centers (P50 Clinical Trial Optional)
Limited submission
Supporting contraceptive research center to develop new methods for men and women, with translational studies for clinical success and fostering early-stage investigators.
This grant is no longer accepting proposals
National Institutes of Health has archived this opportunity.
Funder: National Institutes of Health
Due Dates: October 13, 2025 (Letter of Intent) | November 12, 2025 (Full Application)
Funding Amounts: Up to $1.3M/year direct costs (max 4 years); NIH intends to fund up to 3 awards, total $6M in FY26
Summary: Supports multidisciplinary centers to develop new or improved contraceptive methods for men and women, including translational studies and early-stage investigator development.
Key Information: Limited submission; multi-project (P50) structure required; clinical trials are optional.
Description
This opportunity from the NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) supports the formation of Contraceptive Development Research Centers. The goal is to advance the development of new and/or improved contraceptive methods for both men and women, using multidisciplinary approaches. The program encourages translational studies to bridge pre-clinical and clinical research, and aims to foster the career development of early-stage investigators in contraceptive research.
Centers are expected to serve as national resources, providing scientific and administrative infrastructure to support innovative research and training. Applications must propose a multi-project structure (P50), including at least two meritorious Contraception Development Research Projects, and may include translational research and optional technical service cores.
